
## **Trustees’ Annual Report for the period** 

**From 02/04/2022                  Period start date   To 01/04/2023 Period end date** 

## **Charity name: Vitiligo Support UK** 

## **Charity registration number: 1170557** 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|To promote and protect the physical and<br>mental  health  of  sufferers  of  vitiligo  in<br>England  and  Wales  by  the  provision of<br>support, education and practical advice and<br>to advance the education of the public in all<br>areas relating to vitiligo|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|Para 1.17 and<br>1.19|Providing advice, advocacy, support, and<br>information to those with vitiligo, their<br>families and friends via our closed support<br>group on Facebook<br>Using social media to signpost services<br>and information.<br>Providing advocacy for patients with vitiligo<br>via membership of committees and working<br>groups within the British Association of<br>Dermatologists (BAD)<br>Leading as patient representative on the<br>Patient Engagement Workstream at the<br>BAD and providing a survey of patients’<br>views on the increase in teledermatology in<br>this period.<br>Leading a patient representative on the<br>development of an app to provide<br>psychosocial support for patients with skin<br>disease in conjunction with Professor<br>Andrew Thompson of the University of<br>Cardiff and Dr Anthony Bewley, consultant<br>dermatologist and chair<br>Psychodermatology UK.|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|We have had regard to the guidance issued<br>by the Charity Commission in respect of<br>public benefit.|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

SORP reference 



Para 1.38 Policy on grant making Para 1.38 Policy on social investment including program related investment Para 1.38 Contribution made by volunteers Other 

## **Achievements and Performance** 

||SORP reference||
|---|---|---|
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|As a charity, we have provided extensive<br>support to our membership in navigating<br>access to dermatology. Waiting lists in<br>dermatology continue to be extremely long,<br>and we are concerned that vitiligo patients<br>are triaged out of secondary care in favour<br>of other inflammatory skin conditions. We<br>provided patients with a guide to talking to<br>your GP about your vitiligo based on the<br>information provided by the Primary Care<br>Dermatology Society.<br>We became part of the Education Sub-<br>committee at the BAD in this period and<br>began work on a psychodermatology<br>project alongside Professor Andrew<br>Thompson of Cardiff University. The aim of<br>this is to provide online content to support<br>patients who are significantly impacted by<br>their skin condition. This is in the absence<br>of any national psychodermatology service<br>for patients.<br>We continued to provide extensive support<br>and advice to patients in our closed<br>Facebook group and used the BAD<br>Guidelines for managing patients with<br>vitiligo to provide standardised advice for<br>our members to enable them to access<br>primary care, shape their treatment and go<br>on to secondary care where appropriate.|



**Additional information (optional)** 



## You may choose to include further statements where relevant about: 

|<br>Achievements against<br>objectives set|<br>Para 1.41||
|---|---|---|
|Performance of fundraising<br>activities against objectives<br>set|Para 1.41||
|Investment performance<br>against objectives|Para 1.41||
|Other|||





## **Financial Review** 

|**Financial Review**|||
|---|---|---|
|Review of the charity’s<br>financial position at the end<br>of the period|Para 1.21|The charity maintained its stable financial<br>position in this period.|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|No material reserves are held due to the<br>charity’s conservative management.|
|Amount of reserves held|Para 1.22|See above.|
|Reasons for holding zero<br>reserves|Para 1.22|See above.|
|Details of fund materially in<br>deficit|Para 1.24|See above.|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|Para 1.23|None.|



## **Additional information (optional)** 

## You may choose to include further statements where relevant about: 

|<br>The charity’s principal<br>sources of funds (including<br>any fundraising)|<br>Para 1.47||
|---|---|---|
|Investment policy and<br>objectives including any<br>social investment policy<br>adopted|Para 1.46||
|A description of the principal<br>risks facing the charity|Para 1.46||
|Other|||





## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|Para 1.25|CIO Constitution|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|Charitable Incorporated Organisation|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|Trustees are appointed by the existing<br>trustees, following the provisions of the<br>constitution.|



## **Additional information (optional)** 

## You may choose to include further statements where relevant about: 

|<br>Policies and procedures<br>adopted for the induction<br>and training of trustees|<br>Para 1.51||
|---|---|---|
|The charity’s organisational<br>structure and any wider<br>network with which the<br>charity works|Para 1.51||
|Relationship with any related<br>parties|Para 1.51||
|Other|||



## **Reference and Administrative details** 

|Charity name|Vitiligo Support UK|
|---|---|
|Other name the charity uses||
|Registered charitynumber|1170557|
|Charity’s principal address|36 Avondale Avenue, Esher, Surrey<br>KT10 0DA|
|||





## **Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or body) entitled**<br>**to appoint trustee (ifany)**|
|---|---|---|---|---|
||Emma Rush|Chair of Trustees|||
||Peter Rush||||
||Kate Burnside||||
||Sara Day||||
||Joanna Jackson||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||



## – Corporate trustees names of the directors at the date the report was approved 

## **Director name** 

Name of trustees holding title to property belonging to the charity 

**Trustee name Dates acted if not for whole year** 



## **Funds held as custodian trustees on behalf of others** 

Description of the assets None held in this capacity 

Name and objects of the charity on whose behalf the assets are held and how this falls within the custodian charity’s objects 

Details of arrangements for safe custody and segregation of such assets from the charity’s own assets 

## **Additional information (optional)** 

## **Names and addresses of advisers (Optional information)** 

**Type of Name Address adviser** 

**Name of chief executive or names of senior staff members (Optional information)** 

## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

**None** 

## **Other optional information** 



## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

**Signature(s)** 

**Full name(s)** 

**Position (eg Secretary, Chair, etc)** 

**Date** 



**Vitiligo Support UK** 


**1170557** 

## **Receipts and payments accounts** 

**CC16a** 

**For the period** 3-Apr-22 2-Apr-23 **To from** 

## **Section A Receipts and payments** 

|**Section A Receipts and payments**|||||
|---|---|---|---|---|
|**A1 Receipts**<br>**-**<br>Donations<br>**1,084**<br>Grant<br>**-**<br>Interest Received<br>**202**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,286**<br>**-**<br>**-**<br>**_Sub total_                             -**<br>**_Total receipts_                    1,286**<br>**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**_Sub total_**_(Gross income for AR)_<br>**A2 Asset and investment sales,**<br>**(see table).**|**to the nearest £**<br>**Restricted**<br>**funds**|**to the nearest £**<br>**Endowment**<br>**funds**|**Total funds**<br>**to the nearest £**|**Last year**<br>**to the nearest £**|
||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**1,084**<br>**-**<br>**202**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,286**|**84**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**84**|
||||||
||**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**||
|||||**-**|
|||||**-**|
||||||
||**-**|**-**|**1,286**|**84**|



|**A3 Payments**<br>Insurance<br>**101**<br>Research Expenses<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                          101**<br>**-**<br>**-**<br>**_Sub total_                              -**<br>**_Total payments_                       101**<br>**_Net of receipts/(payments)_                    1,185**<br>**A5 Transfers between funds**<br>**-**<br>**A6 Cash funds last year end**<br>**-**<br>**_Cash funds this year end_                    1,185**<br>**A4 Asset and investment**<br>**purchases, (see table)**|||||
|---|---|---|---|---|
||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**101**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**101**|**-**|
|||||**84**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**84**|
||||||
||**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**||
||||||
|||||**-**|
||||||
||**-**|**-**|**101**|**84**|
||||||
||**-**<br>**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**<br>**-**|**1,185**<br>**-**<br>**-**<br>**1,185**|**-**|
|||||**-**|
|||||**-**|
|||||**-**|



## **Section B Statement of assets and liabilities at the end of the period** 

**Unrestricted Restricted Endowment funds funds funds** 

**Categories** 

**Details** 

**to nearest £** 

**to nearest £** 

**to nearest £** 



|**B1 Cash funds**|Cash at Bank||**1,185**||**-**||**-**||
|---|---|---|---|---|---|---|---|---|
||||**-**||**-**||**-**||
||||**-**||**-**||**-**||
||**_Total cash funds_**||**1,185**||**-**||**-**||
||(agree balances with receipts and payments<br>account(s))||OK||OK||OK||
||||**Unrestricted**||**Restricted**||**Endowment**||
||||**funds**||**funds**||**funds**||
||**Details**||**to nearest £**||**to nearest £**||**to nearest £**||
|**B2 Other monetary assets**|||**-**||**-**||**-**||
||||**-**||**-**||**-**||
||||**-**||**-**||**-**||
||||**-**||**-**||**-**||
||||**-**||**-**||**-**||
||||**-**||**-**||**-**||
||**Details**||**Fund to which**<br>**asset belongs**||**Cost (optional)**||**Current value**<br>**(optional)**||
|**B3 Investment assets**|||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||**Details**||**Fund to which**<br>**asset belongs**||**Cost (optional)**||**Current value**<br>**(optional)**||
|**B4 Assets retained for the**|||||**-**||**-**||
|**charity’s own use**|||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||||**-**||**-**||
||||**Fund to which**||**Amount due**||**When due**||
||**Details**||**liability relates**||**(optional)**||**(optional)**||
|**B5 Liabilities**|||||**-**||||
||||||**-**||||
||||||**-**||||
||||||**-**||||
||||||**-**||||
|Signed by one or two trustees on<br>behalf of all the trustees|Signature||Print|Name|||Date of<br>approval||
||||||||||
||||||||||



